Analysis

Predictive Price Sensitivity Analysis: Pharma

How do real people react to different copay amounts across different clinical scenarios?

Brox.AI· Published ·Also in Türkçe, 日本語
Who was asked
US patient clones, 900 clones
When
February 2026
How
Predicted responses from Brox clones, each built from a long-form interview with a real person, run on the Brox platform.
The full report Predictive Price Sensitivity Analysis: Pharma Open the report

Section 01: What the study found

  1. #

    7pp

    point drop in willingness for a severe disease despite a 25x copay increase ($10 to $250)

    base 900

  2. #

    37pp

    point drop for a progressive but asymptomatic disease over the same copay range

    base 900

  3. #

    5%

    willingness once prior treatment failures compound with cost, from 30%

    base 900

Section 02: Where this sits

Ask this of your own customers: humans@brox.ai

More in Pharma & HCP

All in Pharma & HCP